The analysis of the level of Treg lymphocytes in the blood of patients with endometrial cancer before and after the surgery -preliminary study ABSTRACT Introduction. The progression of cancer is a complex process involving host-tumour interactions taking place in cancer and in the cancer microenvironment. The tumour remodels the microenvironment into the suppressive profile by various mechanisms. One of the most important elements of this mechanism is the inducing of the infiltration of Treg lymphocytes into cancer and its microenvironment. The aim of the present study was to evaluate the alterations of the Treg cell population in the peripheral blood of patients before and after the surgical treatment for endometrial cancer.
Introduction
The progression of cancer is a complex process involving the host-tumour interactions taking place in cancer and in cancer microenvironment. The tumour remodels the microenvironment into the suppressive profile by various mechanisms. One of the most important elements of this mechanism is the inducing of the infiltration of Treg lymphocytes into cancer and its microenvironment. The association between tumour-infiltrating lymphocytes (TIL) and patient survival has been demonstrated in many cancer studies [1] [2] [3] . The classification of CD3+ T cells into functional subsets has led to the subdivision of cytotoxic lymphocytes and regulatory lymphocytes. TIL with cytotoxic markers are linked with favourable prognosis, while TIL-expressing regulatory markers (Tregs) are related with poor prognosis [4, 5] . At the beginning Tregs were defined by such molecular markers as CD4+ and CD25+ [6] . Further studies demonstrated that Tregs express and 
functionally depend on the transcription factor forkhead box protein P3 (FoxP3) [7] . FoxP3 is a well-accepted marker for Treg cells in cancer studies [7, 8] . [4, [14] [15] [16] [17] . It was proposed that high Foxp3 expression level may become a marker for an immunosuppression level contributing to tumour immune escape [14, 15] . In the invasive front of cervical cancer Foxp3-expressing T cells were associated with invasion and metastasis [19] [20] [21] [22] [23] [24] . The malignant neoplasm destroys, therefore, the host immune response, and the surgical treatment aims to remove the tumour mass radically and to restore the immune response. It was demonstrated that when the degree of surgery radicalism increases the possibility of restoring the immune function also increases [25] [26] [27] . There is no efficient method for the evaluation of surgical treatment radicalism. Because Treg cells are the main cell population that enables cancer cells to escape immune surveillance, the Treg cell population might correspond to a diminishment of the tumour mass in patients and might therefore be a marker of the intensity of the selective suppression of the host immune system and also of the degree of radicalism of the surgical procedure. The aim of the present study was to evaluate the alterations of the Treg cell population in the peripheral blood of patients before and after surgical treatment for endometrial cancer.
Material and methods

Patients
The 24 patients included in the study were treated surgically for endometrial cancer between November 2014 and December 2015 in the Department of Gynaecology and Oncology of the Lukaszczyk Oncological Centre, Bydgoszcz, Poland. The clinical characteristics of patients group are presented in Table 1 .
Patients were treated in line with the accepted management standard; in most cases, this included combination treatment. The surgical treatment was applied primarily in all the patients before the combination treatment, which included radiotherapy, brachytherapy, and chemotherapy. Radiotherapy was delivered to the pelvis in three patients, 20 patients underwent a brachytherapy, and three required systemic treatment. External beam irradiation was delivered at doses of 50.4 Gy in 28 fractions. High-dose rate (HDR) brachytherapy was performed in 20 patients at doses of 10-30 Gy divided into 1-4 fractions. After completion www.journals.viamedica.pl/medical_research_journal of the treatment, response was observed in 21 patients; three of the patients included to our group died because of the progression of uterine cancer. Follow-up visits were held four weeks after completion of treatment and then at three-month intervals. Patient follow-up lasted at least 12 months.
The peripheral blood samples were collected from the endometrial cancer patients before operation and three days after the surgical procedure. The patient's consent was obtained in each case.
Flow cytometry
The samples for the cytometric analysis of the Treg cell population in the whole blood of patients were prepared using Human Regulatory T Cell Staining Kits (eBioscience), according to the manufacturer's instruction with some minor modifications. To the 100 µL of blood, 15 µL of CD4 FITC and CD25 PE cocktail, as well as 5 µL of CD45 APC-Cy7 (Becton Dickinson; BD Biosciences Pharmingen, San Jose, CA, USA), were added. After 30 min of incubation with mAbs (in the dark at 4°C), the cells were washed with Flow Cytometry Staining Buffer, centrifuged for 5 min at 350 × g, and then permeabilised with freshly prepared fixation/permeabilisation buffer (for 40 min in the dark at 4°C). Next, the cells were washed twice by adding 1 × permeabilisation buffer, blocked by normal rat serum (for 15 min in the dark at 40°C) and subsequently stained with anti-human FoxP3 APC antibody or rat IgG2a k APC antibody (in the case of isotype control) for 35 min in the dark at 40°C. After another washing step, the cells were suspended in Flow Cytometry Staining Buffer and analysed using a BD FACS Canto II flow cytometer and BD FACS Diva Software (Becton Dickinson). In each sample, 3 × 104 lymphocytes were collected and gated on SSC × CD45 APC-Cy7 dot-plot. Next, the populations of CD4+ FITC, CD25+ PE, and double positive CD4 and CD25 cells were distinguished among the lymphocytes. Finally, the gate of FoxP3 positive cells was established on the CD4+/CD25+ subpopulation. For each sample, a negative control was performed to measure autofluorescence, and an isotype control was performed to exclude non-specific staining of specific antibodies.
Statistical analysis
The distribution of variables in the study groups of women checked with the use of the Shapiro-Wilk test showed that each of the women was different from normal. The statistical significance between the groups was determined by the Kruskal-Wallis test, one-way analysis of variance by ranks. The Mann-Whitney U test was then used as applicable. All statistical analyses were carried out with the Statistica 8.0 software program (StatSoft Inc., Tulsa, OK, USA). A p value < 0.05 was considered indicative of statistical significance.
Results
CD25+ CD4+ FOXP3+ T cells were found in all the examined peripheral blood samples derived from the endometrial cancer patients in the days before and following applied surgery. We observed differences before and after the surgical procedure in patients treated for endometrial cancer. The highest number of Treg cells in the peripheral blood was demonstrated before the surgical treatment; it diminished statistically significantly following the surgery. No statistically significant differences were identified between the analysed antigens and the age, haemoglobin level, white blood cells, platelet count, the type of the treatment applied before the surgery such as radiotherapy, brachytherapy, concomitant diseases, T-staging, FIGO classification, tumour differentiation grade G, lymph node status, and presence of lesions in the cervix.
Discussion
In the present study it was demonstrated that surgical treatment in endometrial cancer influences significantly the percentages of T lymphocyte subpopulations in blood sera. Statistically significant decreases of the percentage of Foxp3+CD4+CD25+ lymphocytes within the population of CD4+CD25+ lymphocytes and within the population of CD4+ T lymphocytes were observed following the surgical treatment. A similar observation was noted in ovarian cancer, where the percentages of FOXP3+ cells in the subpopulation of CD4+ T lymphocytes found in the peripheral blood of the patients before the surgical procedure were statistically significantly higher than those observed in the peripheral blood of the same patients after the surgical procedure [27] . The suppressive microenvironment in endometrial cancer is thus created by the recruitment of Treg cells into the tumour and its stroma and leads to an increase of the percentage of Treg cell population in the blood serum observed in various cancer patients [7, 8] . In murine models, depletion of Treg cells was observed to promote tumour rejection or inhibit the tumour growth [28, 29] . In uterine cancer, the frequency of Treg cells in peripheral blood mononuclear cells in blood serum was prominently increased, independently of the stage of disease [28, 29] .
The decrease of the percentage of Treg cells in blood sera in patients following radical surgical treatment might be useful in measuring the radicalism of the treatment. The monitoring of the level of selective immune system suppression related to Treg cell blood serum levels during cancer therapy might support a decision to supplement the standard therapy with immunotherapy or to increase the degree of radicalism of the applied therapy.
